Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia.

Autor: Yii YC; Department of Emergency Medicine, China Medical University Hospital, Taichung, Taiwan; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan., Shih HM; Department of Emergency Medicine, China Medical University Hospital, Taichung, Taiwan; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan., Chen CL; Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan., Lai ZL; Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan., Hsu YL; Division of Paediatric Infectious Disease, China Medical University Children's Hospital, Taichung, Taiwan., Lai CH; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan., Hsueh PR; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan; Division of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan. Electronic address: hsporen@gmail.com., Cho DY; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Jan; Vol. 63 (1), pp. 107020. Date of Electronic Publication: 2023 Oct 28.